Pacira Biosciences, Inc.
About
Pacira Biosciences, Inc. (NASDAQ:PCRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty
Apr 16 2026
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
Apr 13 2026
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
Apr 8 2026
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Mar 30 2026
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
Financials
Revenue
$726.41 M
Market Cap
$976.58 M
P/E Ratio
141.88
EPS
0.16